Document:

<PAGE>

                                                                   EXHIBIT 10.33

                         DEPARTMENT OF VETERANS AFFAIRS
                           NATIONAL ACQUISITION CENTER
                           PO BOX 76, BLDG. 37, 90N-M3
                                 HINES, IL 60141

March 8, 2002

Timm Medical Technologies, Inc.
DBA:  Osbun Medical
Attn:  Gerald R. Mattys
6585 City West Parkway
Eden Prairie, MN 55344

Dear Mr. Mattys:

Enclosed is your copy of Blanket Purchase Agreement (BPA) VANAC-90NCPR-02-0001
for Vacuum Erection Devices. The BPA's effective dates are April 1, 2002 to
March 31, 2005.

We are pleased to hear that Timm will be sending a representative to our VISN
Prosthetic Representatives Meeting in Las Vegas. I will call Cameron Johnson as
soon as I receive the final times and dates of the meeting.

If you have any questions or concerns, please call me at (708) 786-5253 or
e-mail patricia.benson@med.va.gov.

Sincerely,

   /s/ PATRICIA BENSON

Patricia Benson
Contracting Officer
National Contracts Service
<PAGE>
DEPARTMENT OF VETERANS AFFAIRS
VACUUM ERECTION DEVICES
BLANKET PURCHASE AGREEMENT
REQUEST FOR QUOTATION

RFQ NO. NCPR000001                      BPA NO. VANAC-90NCPR-02-001

CONTRACT NO. V797P-3456K                DUE DATE:  November 26, 2001

This is a request for a Blanket Purchase Agreement (BPA) quotation pursuant to
Clause I-FSS-646-A of your Federal Supply Schedule (FSS) contract. The
Department of Veterans Affairs (VA) Prosthetics and Sensory Aids Service (PSAS)
intends to establish a national mandatory source for Vacuum Erection Devices
(VED) for PSAS and to secure the lowest price possible for these products. PSAS
intends to standardize on VEDs that will be evaluated and determined to meet
PSAS's needs. Upon reaching mutual agreement on price and terms, this document
will be executed by both parties thereby making the BPA effective.

      1. SCOPE

      The following provides an overview of the terms and conditions of this BPA
request:

      a)    In exchange for becoming a mandatory source, VA requests additional
            price considerations for VEDs.
      b)    All sales under this agreement will be attributable to the BPA
            Contractor's current FSS contract and subject to the Industrial
            Funding Fee (IFF).
      c)    A BPA will be established with the offeror whose quote offers the
            best overall value to VA, considering product conformity to
            specifications, availability of patient education and post treatment
            follow up, price, and past performance.
      d)    This BPA, including product prices and other terms and conditions,
            is public information and is releasable under the Freedom of
            Information Act (FOIA). Procurement related information, including
            negotiations, shall be treated as confidential and shall not be
            disclosed except as required by applicable laws and regulations.
      e)    Specifications:
            1.    Single-handed operation
            2.    Manually controlled
            3.    Must have pressure release valve
            4.    Includes several sizes of bands
      f)    Evaluation Factors: See Attachment A

2.    PERIOD OF AGREEMENT

      This BPA is effective 45 days after (or earlier by mutual consent) the
      date signed by the Government and expires two years thereafter or at the
      end of the FSS contract period (including extensions, if any), whichever
      is earlier. If a new FSS contract is awarded to Contractor before this BPA
      expires, the parties by mutual agreement may establish a follow-on BPA
      against the new FSS contract for the remaining term of this BPA. The
      follow-on BPA shall cover the products covered by this BPA and shall
      contain terms and conditions substantially the same as the terms and
      conditions of this BPA. The maximum term of this BPA and follow-on BPA, if
      any, shall be two years from the effective date of this BPA. A Government
      review of the estimated purchases and the corresponding discounts for this
      BPA will be performed annually. If a follow-on BPA is contemplated, a
      review of the estimated purchases and the corresponding discounts will be
      performed before the follow-on BPA is established and annually thereafter.
<PAGE>
3.    PRODUCT EVALUATION

      PSAS and the National Acquisition Center will evaluate sample VEDs which
      are offered in response to this offer. See Attachment A.

4.    UNINTERRUPTED SOURCE OF SUPPLY

      By signing this BPA, the offeror guarantees to provide an uninterrupted
      source of supply of the originally awarded item(s) to satisfy PSAS's
      requirement for the performance period of the awarded BPA. If, however,
      the contractor determines to terminate production of the awarded item(s)
      and contemplates replacement with alternative item(s), VA reserves the
      right to evaluate the potential replacement item(s). There is no guarantee
      that VA will evaluate any replacement item(s) favorably. If VA determines
      the replacement item(s) is unacceptable, the individual item(s) or the
      entire BPA may be cancelled.

5.    ESTIMATED VOLUME

      PSAS's Data Validation Group (DVG) indicates the estimated annual volume
      of purchases is approximately 16,000 units.

6.    AGGREGATE PURCHASES LESS THAN ESTIMATED VOLUME OF PURCHASES.

      If the Government does not achieve the estimated volume of purchases, the
      Contractor hereby waives any right to collect the difference in price
      between the actual level achieved and the anticipated level.

7.    AWARD ON INITIAL OFFERS

      The Government intends to evaluate proposals and award a BPA without
      discussions with offerors (except communications conducted for the purpose
      of minor clarifications). Therefore, each initial offer should contain the
      offeror's best price. However, the Government reserves the right to
      conduct discussions at the contracting officer's discretion.

8.    EXTENT OF OBLIGATION

      The Government is obligated only to the extent of authorized purchases
      made under this BPA. This BPA does not obligate any funds.

9.    SALES REPORTS

      The contractor's quarterly reports of sales will also include these
      purchases and reflect the appropriate discount given.

10.   NOTICE OF INDIVIDUALS AUTHORIZED TO PURCHASE UNDER THE BPA

      Any individual who has authorized ordering/contracting authority, on
      behalf of VA's PSAS to place delivery (purchase) orders may use this BPA.

11.   ORDERING METHOD

      Orders will be placed against this BPA via Electronic Data Interchange
      (EDI), if the contractor has this capability; facsimile; in writing; or by
      phone.
<PAGE>
12.   DELIVERY TICKETS

      Unless otherwise agreed to, all deliveries under this BPA must be
      accompanied by delivery tickets or sales slips that must contain the
      following information as a minimum:

            a)    Name of contractor
            b)    Contract Number
            c)    BPA Number
            d)    Model Number or National Stock Number (NSN)
            e)    Purchase Order Number
            f)    Date of Purchase
            g)    Quantity, unit price, and extension of each item (unit prices
                  and extensions need not be shown when incompatible with the
                  use of automated systems, provided that the invoice is
                  itemized to show the information); and
            h)    Date of shipment

13.   INVOICES

      An itemized invoice shall be submitted to the VA billing address listed on
      each deliver (purchase) order. The requirement of a proper invoice are as
      specified in the FSS contract. The itemized invoice shall identify the
      delivery ticket or packing list, ship-to-address of supplies, the BPA
      number, and the delivery (purchase) order number assigned by the
      individual facility at the time of ordering.

14.   REPORTS

      The contractor shall provide a quarterly report of sales broken out for
      each medical center within 30 days after the close of each quarter's
      business. Reports should reflect total sales by line item number for each
      medical center. Reports shall be sent to the following address:

           Department of Veterans Affairs
           National Acquisition Center
           National Contracts Division (90N-C-PR)
           P.O. Box 76, Hines, IL 60141-0076

15.   BPA MODIFICATIONS

      This BPA may be modified by mutual agreement of the Government and
      Contractor. Each such modification shall be in writing, issued by the VA
      National Acquisition Center, and signed by the Government and the
      Contractor. Modifications shall become effective on the date signed by the
      Government.

16.   CANCELLATION

      Each party may terminate this agreement at any time by giving to the other
      written notification of its intent to do so, not less than 30 days prior
      to the effective date of the termination.

17.   ORDER OF PRECEDENCE

      All FSS contract terms and conditions apply to this BPA unless modified by
      the BPA. The terms and conditions of this BPA apply to all purchases made
      pursuant to it. In the event of an inconsistency between the provision of
      this BPA and the Contractor's invoice, the provisions of this BPA will
      take precedence.
<PAGE>
18.   DEADLINES FOR QUOTES

      Contractor quotations are to be delivered no later than 4.00 p.m. (CST) on
      November 26, 2001. Quotes submitted after this time will not be
      considered. Quotes may be faxed or mailed to the address listed below. If
      faxed, an original document with signatures must be submitted to the a
      timely manner.

Timm Medical Technologies, Inc.

/s/ GERALD R. MATTYS                              21 Nov 01
-----------------------------------------     ---------------------------------
Gerald R. Mattys                              Date Signed
Authorized Negotiator

/s/ (Illegible)                                   2/26/02
-----------------------------------------     ---------------------------------
Government Contracting Officer                Date Signed

VA National Acquisition Center
ATTN:  Patricia Benson
National Contracts Service
1st  Avenue, One Block North of Cermak
Building 37
Hines, IL 60141

Telephone:        (708) 786-5253
Fax:              (708) 786-5256
<PAGE>
                        ADDITIONAL INFORMATION REQUESTED

Company Name:                     Timm Medical Technologies, Inc.
                                  DBA: Osbon Medical
                                  6585 City West Parkway
                                  Eden Prairie, MN 55344

Phone:                            (952) 947-9410, (800) 683-8938, (800) 344-9688

Facsimile:                        (952) 947-9411

Contractor Number:                V797P-3456K

Expiration Date of FSS Contract:  January 31, 2004

Business Size:                    Small (less than 100 employees)

Payment Terms:                    2%-30 ARO [No Change from FSS]

Delivery:                         Within 30 days [No Change from FSS]

Emergency Delivery:               Within 5 days ARO [No Change from FSS]

Minimum Order:                    $100 [No Change from FSS]

Are any of the items offered under this BPA foreign?  NO

Does your company currently accept the Government Credit Card?  YES

Is your company EDI capable?  YES
<PAGE>
                                  ATTACHMENT A

                      (a) Vacuum Erection Device Quotation

Product:                   Osbon Erecaid(R)
                           Esteem(TM) Manual System

Model Number:              1130

Offered price:             $79.95

Specifications:
                           Stated:
                           1.  Single-handed operation
                           2.  Manually controlled
                           3.  Pressure release valve`
                           4.  Four different sizes and tensions of bands

                           Additional Specifications:
                           1.  Easy-action tension band (ring) loader
                           2.  Tube of Osbon personal lubricant
                           3.  Travel case
                           4.  Patient instructional video and user guide

Additional Warranties:

l. During the term of this BPA, Timm Medical will maintain a medically certified
domestic field organization of no less than 30 certified Clinical Technicians,
to perform clinical applications/demonstrations to any and all VA patients
purchasing, or having already purchased, an Osbon VED.

2. To ensure that product warranty obligations will be met for the life of any
Osbon VED purchased by the VA, Timm Medical will maintain a working capital
level of no less than $2 million for the duration of this BPA.

3. During the term of this BPA, Timm Medical will maintain $5,000,000 of
comprehensive liability coverage on all VED products and related services.
<PAGE>
               (c) Patient Education and Post Treatment Follow-up

Included in the Offered Price are the following services:

1.    PATIENT TRAINING

            The American Urological Association recommends any men interested in
            trying vacuum therapy to be given individual instruction in its use.
            Patients who rely on the manufacturer's printed or videotaped
            instructions are less likely to master the use of the vacuum device
            than those given a demonstration by a physician or experienced
            technician.

            Erectile Dysfunction Guidelines Developed for Primary Care by the
            Department of Veteran Affairs (May, 2000) states "The successful
            utilization of a vacuum tumescence device depends on appropriate
            patient education and counseling . . . Compliance and acceptance of
            the therapy have been shown to be dependent on individualized
            instruction . . . by a fully trained, qualified instructor . . .
            Qualified instructors may include urologists, physician extenders,
            nurse specialists, or certified manufacturer representatives."

Because the quality of the patient training is only as good as the quality of
the training of the individuals delivering that patient training, Timm Medical
has established a training standard that is second to none. The Osbon Vacuum
products are solicited and detailed by professionally trained Clinical
Technicians who complete a certification process accredited by the Certification
Board of Urologic Nurses and Associates. No other vacuum device company offers
this accreditation nor meets the requirements for accreditation. This
certification process includes annual product and medical-condition education.
Participants in the training are required to demonstrate their knowledge before
being permitted to participate in patient consultations. Copies of the stringent
qualifications for clinical certification and our current CBUNA certificate are
attached (Addendum A-l).

Timm's unique training program ensures that VA patients will receive proper
instruction in the use and maintenance of their Osbon vacuum device, optimizing
patient satisfaction. Timm Medical will guarantee that a certified clinical
technician will be available to each VA patient prior to, and following, the
dispensing an Osbon ErecAid Esteem Manual System.

2. 24 HOUR PATIENT SUPPORT

Timm Medical provides toll-free, 24-hour, 7 day-a-week patient support services,
available to all registered Osbon ErecAid owners, staffed by Certified Osbon
Technical Advisors. These personnel are supervised by Board Certified Urologists
who are available to augment and lend expertise to any impotence training
provided by VA healthcare professionals.

3. PATIENT FOLLOW-UP

Timm Medical's certified Technical Advisor's conduct post-purchase customer
follow-up (via phone and mailer) to ensure that all patient questions and
concerns have been addressed. Any VA patient receiving an Osbon ErecAid System
may request additional product demonstrations, performed by their certified
Clinical Technician.

Through computer registration and voluntary responses to questionnaires, Timm
Medical has gathered the most comprehensive patient information database
available. This data was first published in medical literature in 1989. With
hundreds of thousands of ErecAid Systems prescribed, this database represents
the largest single source of significant medical information validating the use
of vacuum therapy in the medical management of erectile dysfunction. The Osbon
ErecAid System claims a substantial body of clinical studies from hospitals and
universities in many countries which support an effectiveness rating of over 90%
for erectile dysfunction of almost any etiology. THE OSBON ERECAID SYSTEM IS THE
ONLY EXTERNAL VACUUM DEVICE TO HAVE OVER 20 PUBLISHED STUDIES DOCUMENTING
SAFETY, EFFECTIVENESS AND PATIENT ACCEPTANCE.

4. PROFESSIONAL EDUCATIONAL MATERIAL

Timm Medical provides, free-of-charge, comprehensive educational materials on
the causes and treatments of erectile dysfunction to VA healthcare
professionals. This information is available in both booklet and video form.
<PAGE>
A sample of this information (i.e. the Couple's Guide for the treatment of
Erectile Dysfunction) is enclosed (Addendum A-4).

5. REGULATORY COMPLIANCE (MANUFACTURING STANDARDS)

Timm Medical's facilities are well equipped and registered to produce FDA Class
I, II and III medical devices, with full ISO 9001, EN 46001 and CE mark
certifications. Timm Medical is routinely inspected by the FDA, and has always
maintained a "good standing" rating.

6. 90 DAY REFUND POLICY

All Osbon vacuum devices carry an unmatched 90-day refund policy. The policy
provides for a 100% refund if the patient is not completely satisfied. In the
VA's case, Timm Medical will refund the VA by either replacing a returned system
with a new System or, at the discretion of the VA, by issuing a credit.

7. LIFETIME WARRANTY

Timm Medical provides a lifetime warranty on the major components of each Osbon
ErecAid System. All registered owners may return the components directly to Timm
Medical for free replacement.

8. LIABILITY INSURANCE

Timm Medical maintains $5,000,000 of comprehensive liability coverage on all
products and services. In addition to the stringent professional training,
product quality, and regulatory compliance specifications delineated above, Timm
Medical's Product and Professional Liability Underwriting Standards include the
following requirements:

A.  Quality Control Standards
-     regularly survey customers on product and service satisfaction
-     monitor customer phone calls for quality of service
-     proactively solicit customer registration and communication
-     inspect all raw materials and components and institute quality testing as
      dictated under Military Standard 105-E for components delivered by
      suppliers
-     inspect and investigate all returned product and components to allow for
      continuous improvement

B. Product Safety

To date, no serious injury from the use of an Osbon ErecAid System has ever been
reported from over 450,000 owners. Product design also contributes to user
safety. The vacuum mechanism has a built-in limiter, a vacuum release valve, and
cylinder inserts for appropriate sizing and comfort. To enhance customer safety,
Timm Medical retains Board Certified Urologists who educate Timm employees,
physicians and the general public on the diagnosis, evaluation and treatment
options. Timm's Medical Directors are also responsible for the administration of
the Certification Board for Urologic Nurses and Associates accredited
certification program. Timm Certified Clinical Technicians train and educate
patients on the proper use of the Osbon ErecAid System in a clinical setting.
CBUNA is the organization which accredits urology nurses and physician
assistants.

C. Loss Experience

There has never been a claim paid for an injury nor has a lawsuit ever gone to
trial.

D. Approval Listings

The required 510(k) documents were submitted to the U.S. Department of Health
and Human Services, which subsequently determined that all impotence management
products made by Timm could be advertised and sold in the marketplace. Marketing
permission is subject to the company's adherence to the general controls
provisions of the Federal Food, Drug and Cosmetic Act. Those provisions include
regulations regarding annual registration, listings of devices, good
manufacturing practices, and specific standards regarding labeling, misbranding,
and adulteration of devices. The Osbon ErecAid was the first external vacuum
device to receive marketing approval under federal guidelines.

E. Recall Procedures

The recall policy of Timm Medical is in full compliance with the FDA's Recall
Guidelines Section 7.40 of code of Federal Regulation. The company agrees that a
recall, a market withdrawal, or stock recovery is an effective
<PAGE>
method of protecting the public health and well being from products deemed to
present a risk of injury, gross deception or other defect.

F. Medically Accredited Training Program and Full Time Medical Staff

Timm Medical retains Board Certified Urologists who oversee the accredited
certification program for clinical technicians and technical advisors. This
program is accredited by CBUNA testing body for the urologic health
professionals.
<PAGE>
                                                                       FILE COPY

DEPARTMENT OF VETERANS AFFAIRS
VACUUM ERECTION DEVICES
BLANKET PURCHASE AGREEMENT (BPA)
REQUEST FOR QUOTATION

RFQ NO. NCPR000001                  BPA NO. VANAC-90NCPR-02-001
AMENDMENT 1

Several Veteran's Integrated Service Networks (VISN) have committed to purchase
VEDs through VISN level BPAs for a one year period that expires September 30,
2002. These VISNs will not begin to purchase under this BPA until October 1,
2002.

This exclusion could decrease the Government's estimate for the first year of
the BPA by approximately 4,000 units.

Also, this Amendment increases the term of the Blanket Purchase Agreement from
two years to three years.

Since this Amendment may affect prices offered, offerors may change their
offered prices by contacting the Contracting Officer in writing by December 13,
2001.

_____________   We are not changing our original offered price.

______x______   We are changing our original offered price to $89.95.
                (Effective until 9/30/02. After September 30, price will
                decrease to original proposed bid price of $79.95 for remainder
                of 3 year term)

/s/ STEPHEN P. ZASTROW
------------------------------------
Signature

Stephen P. Zastrow
------------------------------------
Name (Printed)

Timm Medical Technologies
------------------------------------
Company Name

12-12-01
------------------------------------
Date<PAGE>
                                                                               .
                                                                               .
                                                                               .
                                                                   Exhibit 10.34

                       EXECUTIVE SEPARATION BENEFITS PLAN

                                TABLE OF CONTENTS
<TABLE>
<CAPTION>
                                                                             Page

<S>                                                                          <C>
Section 1 General Information...............................................   1

Section 2 Definitions.......................................................   1

Section 3 Benefits under the Plan...........................................   5

Section 4 Plan Amendment and Termination....................................   9

Section 5 Plan Administration...............................................   9

Section 6 Miscellaneous Matters.............................................  11

Section 7 Claims Procedure..................................................  12

Section 8 ERISA Rights......................................................  14

Summary Plan Description Information........................................  17

Appendix A to the Endocare, Inc. Executive Separation Benefits Plan.........  18

Appendix B to the Endocare, Inc. Executive Separation Benefits Plan.........  19
</TABLE>

                                       i
<PAGE>

                                   SECTION 1

                               GENERAL INFORMATION

      1.1. ADOPTION AND PURPOSE OF PLAN. The Employer hereby adopts this
Executive Separation Benefits Plan to provide certain Separation Benefits to
Eligible Employees in accordance with the terms and conditions of the Plan.

      1.2. STATUS OF PLAN. The Plan is intended to comply with all applicable
state and federal laws regarding severance pay plans, specifically Title I of
ERISA. The Plan is intended to be a "welfare benefit plan," as defined in ERISA
Section 3(1) and Department of Labor Regulation Section 2510.3-1.

      1.3. SUMMARY PLAN DESCRIPTION. The Plan Administrator is hereby authorized
to use this document embodying the Plan and all supplementary materials, as from
time to time amended, to satisfy all of the Plan's "summary plan description"
requirements pursuant to ERISA.

      1.4. EFFECTIVE DATE. The Plan is effective as of July 17, 2002.

      1.5. PLAN YEAR. For recordkeeping and reporting purposes, the Plan Year
shall be the 12-month period ending each December 31. Notwithstanding the
foregoing, the initial Plan Year shall begin on July 17, 2002 and end on
December 31, 2002.

                                    SECTION 2
                                   DEFINITIONS

      2.1. "Base Pay" means an Eligible Employee's highest annual base salary
rate paid during the twenty-four months (or total period of employment, if less)
immediately preceding termination of the employee's employment due to a Covered
Termination plus the maximum amount of any bonus payable to the Eligible
Employee in such period under a written bonus plan of the Company. The term Base
Pay shall exclude all other types of compensation or remuneration to an Eligible
Employee, and shall exclude without limitation, overtime pay and shift
differentials, contributions (other than employee salary-reduction
contributions) to any retirement or other employee benefit plans, commissions,
profit sharing payments, incentive payments of any kind, special payments of any
kind (including without limitation business expense reimbursements, tuition
reimbursements and flexible spending account reimbursements) and contingent
compensation of any kind.

      2.2. "Board" means the Employer's Board of Directors.

      2.3. "Cause" means an Eligible Employee's (a) willful and continuing
failure to substantially perform duties assigned in good faith from time to time
by the Employer (provided that such failure is not solely the result of (i) a
disability entitling the Eligible Employee to benefits under the Employer's
long-term disability plan or Medicare, (ii) a leave of absence either granted in
writing by the Employer or guaranteed by applicable law or (iii) some other
reason agreed to in advance by either the Employer's Chairman or a majority of
its Board); or (b) willful conduct which is demonstrably and materially
injurious to the Employer; or

                                       1
<PAGE>

(c) conviction of a felony or a misdemeanor involving the theft,
misappropriation or embezzlement of property of the Employer.

      No termination of an Eligible Employee's employment shall be for Cause
unless: (a) notice of such Cause is provided to the employee by or on behalf of
the Board; and (b) no valid prior or simultaneous notice of Good Reason has been
given by the employee; and (c) the employee is afforded an opportunity to be
heard before the Board and represented by counsel; and (d) a majority of the
Board then determines that Cause exists for the employee's termination; and (e)
only if and to the extent a cure-period is permitted under any separate written
agreement between the Employer and the employee and cure is feasible, the
employee has failed to timely cure such asserted Cause. The required hearing
need not be held before the Eligible Employee's termination occurs, but it must
be held within 30 days after the required notice of asserted Cause is given to
the Eligible Employee, unless the employee agrees to a postponement.

      For purposes of this Subsection, the term Board shall include the board of
directors (or body with a similar function) of the Employer's successor
following a Change in Control.

      2.4. A "Change In Control" of the Employer will occur upon:

            (a) The acquisition by any individual, entity or group (within the
      meaning of Sections 13(d)(3) or 14(d)(2) of the Securities Exchange Act of
      1934 (the "Exchange Act")) (a "Person") of beneficial ownership (within
      the meaning of Rule 13d-3 promulgated under the Exchange Act) of 50
      percent or more of either (i) the then outstanding shares of the
      Employer's common stock (the "Common Stock") or (ii) the combined voting
      power of the then outstanding voting securities of the Employer entitled
      to vote generally in the election of the directors (the "Outstanding
      Employer Voting Securities"); provided, however, that the following
      acquisitions shall not constitute a Change in Control: (A) any acquisition
      directly from the Employer (including an equity financing); (B) any
      acquisition by the Employer or by any corporation controlled by the
      Employer; (C) any acquisition by any employee benefit plan (or related
      trust) sponsored or maintained by the Employer or any corporation
      controlled by the Employer; or (D) any acquisition by any corporation or
      business entity pursuant to a consolidation or merger, if, following such
      consolidation or merger, the conditions described in clauses (i) and (ii)
      of paragraph (c) of this definition are satisfied; or

            (b) At any time, individuals who, as of the Effective Date,
      constitute the Board (the "Incumbent Board") cease for any reason to
      constitute at least a majority of the Board; provided, however, that any
      individual becoming a director subsequent to the Effective Date whose
      election, or nomination for election by the Employer's stockholders, was
      approved by a vote or resolution of at least a majority of the directors
      then comprising the Incumbent Board shall be considered as though such
      individual were a member of the Incumbent Board, but excluding, for this
      purpose, any such individual whose initial assumption of office occurs as
      a result of either an actual or threatened election contest (as such terms
      are used in Rule 14a-11 of Regulation 14A promulgated under the Exchange
      Act) or other actual or threatened solicitation of proxies or consents by
      or on behalf of a Person other than the Board.

                                       2
<PAGE>

            (c) Adoption by the Board of a resolution approving an agreement of
      consolidation of the Employer with or merger or similar transaction of the
      Employer into another corporation or business entity in each case, unless,
      following such consolidation or merger, (i) more than 50 percent of the
      combined voting power of the then outstanding voting securities of such
      corporation or business entity entitled to vote generally in the election
      of directors (or other persons having the general power to direct the
      affairs of such entity) is then beneficially owned, directly or
      indirectly, by the beneficial owners, respectively, of the Common Stock
      and Outstanding Employer Voting Securities immediately prior to such
      consolidation or merger in substantially the same proportions as their
      ownership, immediately prior to such consolidation or merger, of the
      Common Stock and/or Outstanding Employer Voting Securities, as the case
      may be and (ii) at least a majority of the members of the board of
      directors (or other group of persons having the general power to direct
      the affairs of the corporation or other business entity) resulting from
      such consolidation or merger were members of the Incumbent Board at the
      time of the execution of the initial agreement providing for such
      consolidation or merger; provided that any right which shall vest by
      reason of the action of the Board pursuant to this paragraph (c) shall be
      divested, with respect to any such right not already exercised, upon (A)
      the rejection of such agreement of consolidation or merger by the
      stockholders of the Employer or (B) its abandonment by either party
      thereto in accordance with its terms.

            (d) Adoption by the requisite majority of the whole Board, or by the
      holders of such majority of stock of the Employer as is required by law or
      by the Certificate of Incorporation or By-Laws of the Employer as then in
      effect, of a resolution or consent authorizing (i) the liquidation or
      dissolution of the Employer or (ii) the sale or other disposition of all
      or substantially all of the assets of the Employer, other than to a
      corporation or other business entity with respect to which, following such
      sale or other disposition, (A) more than 50 percent of the combined voting
      power of the then outstanding voting securities of such corporation or
      other business entity entitled to vote generally in the election of
      directors (or other persons having the general power to direct the affairs
      of such entity) is then beneficially owned, directly or indirectly, by the
      beneficial owners, respectively, of the Common Stock and Outstanding
      Employer Voting Securities immediately prior to such sale or other
      disposition in substantially the same proportions as their ownership,
      immediately prior to such sale or other disposition, of the Common Stock
      and/or Outstanding Employer Voting Securities, as the case may be, and (B)
      at least a majority of the members of the board of directors (or other
      group of persons having the general power to direct the affairs of such
      corporation or other entity) were members of the Incumbent Board at the
      time of the execution of the initial agreement or action of the Board
      providing for such sale or other disposition of assets of the Employer;
      provided that any right which shall vest by reason of the action of the
      Board or the stockholders pursuant to this paragraph (d) shall be
      divested, with respect to any such right not already exercised, upon the
      abandonment by the Employer of such dissolution, or such sale or other
      disposition of assets, as the case may be.

            (e) Any other event which constitutes a change of control as defined
      in Employer's 1995 Stock Plan.

                                       3
<PAGE>

A Change in Control shall not occur upon the mere reincorporation of the
Employer in another state or setting up a new holding company.

      2.5 "Committee" means the committee appointed by the Board to administer
the Plan.

      2.6 "Covered Termination" means the termination of an Eligible Employee's
employment either (i) by the Eligible Employee for Good Reason after a Change in
Control, (ii) by the Eligible Employee for any reason or no reason during the
30-day period immediately following the six month anniversary of the closing of
a transaction resulting in a Change in Control or (iii) voluntarily by the
Employer (or its successor following a Change in Control) after a Change in
Control for a reason other than Cause, death or disability. However, in no event
shall transferring employment from a parent to a subsidiary corporation (or vice
versa) constitute a Covered Termination.

The term Covered Termination shall not include the transfer of the Eligible
Employee's employment to the Employer's successor following a Change in Control,
provided that such transfer does not constitute or result in the employee having
Good Reason to resign.

      2.7 "Effective Date" means the date set forth in Subsection 1.4 above.

      2.8 "Eligible Employee" means an individual who either is designated on
Appendix A to this Plan, as amended by the Committee from time to time, as of
the date of a Covered Termination.

      2.9 "Eligibility Conditions" means the conditions on eligibility for
Separation Pay set forth in Subsection 3.2 below.

      2.10 "Employer" means Endocare, Inc., a corporation organized under the
laws of Delaware, and its subsidiaries. To the extent required to carry out the
intent of this Plan, the term Employer shall also refer to the Employer's
successor following a Change in Control.

      2.11 "ERISA" means the Employee Retirement Income Security Act of 1974, as
amended.

      2.12 "Good Reason" means an Eligible Employee's resignation from his or
her employment due to: (a) a substantial reduction imposed by the Employer in
the responsibilities of the employee's position with the Employer; or (b) a
reduction in the employee's Base Pay unless such reduction affects all similarly
situated individuals; or (c) the elimination or impairment of the employee's
eligibility for compensation or benefits programs generally available to other
Eligible Employees unless such elimination or impairment affects all similarly
situated individuals; or (d) a requirement imposed by the Employer that the
employee relocate to a new post at least 50 miles from his or her then-existing
post; or (e) the employee has not been offered continued employment with the
Employer or its successor following a Change in Control on substantially the
same terms and conditions of employment as were in effect for the employee
immediately prior to the Change in Control.

      No resignation by an Eligible Employee shall be for Good Reason unless:
(a) notice of such Good Reason is provided to the Board by or on behalf of the
Eligible Employee and (b) the

                                       4
<PAGE>

Employer fails to cure such asserted Good Reason within 30 days after receipt of
such notice; provided that the Employer shall have the sole discretion to
determine whether or not (i) to attempt or complete such a cure or (ii) to
dispute in good faith or accept the existence of such Good Reason.

      For purposes of this Subsection, the term Board shall include the Board of
Directors (or body with a similar function) of the Employer's successor
following a Change in Control.

      2.13 "Participant" means an Eligible Employee who is entitled to receive
Separation Benefits under the terms and conditions of the Plan.

      2.14 "Plan" means the Employer's Executive Separation Benefits Plan as set
forth in this document and in any and all amendments and supplements to this
document.

      2.15 "Plan Administrator" means the person responsible for satisfying the
reporting and disclosure obligations of ERISA, which shall be the Employer.

      2.16 "Plan Year" means the relevant period set forth in Subsection 1.5
above.

      2.17 "Separation Benefits" means Separation Pay and the other benefits
provided pursuant to Section 3.1.

      2.18 "Separation Benefits Period" means, for any Participant, the period
equal to the number of months of Base Pay to be received by the Participant as
Separation Pay. However, a Participant's Separation Benefits Period shall end
earlier upon the Participant's failure to continue satisfying all Eligibility
Conditions.

      2.19 "Separation Pay" means the continuation of a Participant's Base Pay
during the Separation Benefits Period in accordance with the terms and
conditions of the Plan.

                                   SECTION 3
                             BENEFITS UNDER THE PLAN

      3.1 TYPES OF BENEFITS. An Eligible Employee whose employment with the
Employer (or its successor following a Change in Control) is terminated solely
due to a Covered Termination and with respect to whom all applicable Eligibility
Conditions set forth in Subsection 3.2 below are met shall be entitled under
this Plan to the following types of Separation Benefits:

            (a) Separation Pay as determined under Subsection 3.3 below; and

            (b) Continued eligibility for certain employee benefit programs, as
      described in Subsection 3.4 below.

      3.2 ELIGIBILITY CONDITIONS; NO MITIGATION. Notwithstanding anything else
in this Plan, Separation Benefits shall be provided under this Plan only to an
Eligible Employee whose employment with the Employer (or its successor following
a Change in Control) actually terminates solely due to a Covered Termination.
Furthermore, no Eligible Employee shall be

                                       5
<PAGE>

entitled to commence or continue receiving Separation Benefits under the Plan
unless all of the following conditions are met and (to the extent applicable)
continue to be met at all times:

            (a) The Eligible Employee must agree to and must sign and comply
      with a separation letter satisfactory to the Employer (or its successor
      following a Change in Control). The separation letter may include, without
      limitation:

                  (i) a comprehensive release of all claims of any sort against
            the Employer (and its present and former parents and subsidiaries
            and its successor following a Change in Control (collectively, the
            "Employer Group")) and all agents, employees, advisors and other
            representatives of the Employer Group in a form reasonably
            satisfactory to the Employer;

                  (ii) an acknowledgment that except as expressly provided for
            pursuant to Section 6.3, this Plan shall exclusively govern any
            claims for any type of severance benefits as a result of the
            termination of the Eligible Employee's employment; and

                  (iii) an acknowledgment that any then-existing agreements
            concerning nonsolictation, confidentiality and/or non-competition
            binding on the Eligible Employee will remain in effect in accordance
            with their terms.

            (b) If not already fully paid or terminated for any other reason, a
      Participant's Separation Benefits shall cease as of the first date of any
      breach or other failure if the Participant breaches the terms of any
      separation letter or non-competition agreement entered into with the
      Employer pursuant to the requirements of clauses (a)(i), (a)(ii) or
      (a)(iii) above or otherwise materially fails to satisfy any obligations of
      the Participant to the Employer under this Plan.

            (c) If not already fully paid or terminated for any other reason, a
      Participant's Separation Benefits shall cease as of the first date of any
      misconduct if the Employer becomes aware of any instance of the
      Participant's misconduct that would have constituted Cause for termination
      of the Participant's employment, whether such misconduct occurs prior to
      or following the Participant's termination of employment with the
      Employer; but provided that the notice, hearing and Board majority
      decision requirements of Subsection 2.3 are met promptly after discovery
      of the misconduct.

            (d) A Participant shall not be required to seek replacement
      employment as a condition of receiving Separation Benefits. Thus, a
      Participant shall not be required to mitigate damages in any fashion.

                  (i) AMOUNT OF SEPARATION PAY. Effective for Covered
            Terminations made on or after the Effective Date while this Plan
            remains in effect and subject to Subsection 3.2, each Participant's
            Separation Pay shall equal a lump sum amount specified for the
            Participant in Appendix B to this Plan.

      3.3 PAYMENT OF BENEFITS. Subject to Subsection 3.2, Separation Pay shall
be paid to the Participant in one lump sum at the time of (or as soon as
possible after) the Participant's

                                       6
<PAGE>

Covered Termination. Notwithstanding the foregoing, if the Plan Administrator
receives written notice that the Participant dies or is mentally incompetent,
the Employer shall pay the balance of the Participant's Separation Pay only to
the Participant's duly appointed legal representative.

      3.4 CONTINUED ELIGIBILITY FOR BENEFIT PROGRAMS. Subject to Subsection 3.2,
during the Separation Benefits Period, the Participant (and his or her
dependents, as applicable) shall be provided by the Employer with the same life,
health and disability plan participation, benefits and other coverages to which
he was entitled as an employee immediately before the Covered Termination. In
the event that under applicable law the terms of the relevant employee benefit
plan such participation, benefits and/or coverage cannot be provided to
Participant following his or her Covered Termination, such coverage and/or
benefits shall be provided directly by the Employer pursuant to this Plan on a
comparable basis. In its sole discretion, the Employer may obtain such coverage
and benefits for Participant through private insurance acquired at the
Employer's expense. Amounts paid or payable on behalf of a Participant pursuant
to any "employee welfare benefit plan" as defined by ERISA, providing health
and/or disability benefits, that is sponsored by Employer or an affiliate of the
Employer, shall be credited against amounts due under this Section 3.4. To the
maximum extent permitted by applicable law, the benefits provided under this
Section 3.4 shall be in discharge of any obligations of Employer or any rights
of Participant under the benefit continuation provisions under Section 4980B of
the Internal Revenue Code (the "Code") and Part VI of Title I of ERISA ("COBRA")
or any legislation of similar import.

      3.5 CERTAIN BENEFITS NOT AVAILABLE. As required by applicable law,
Participants will not be able to make pre-tax contributions to a Section 401(k)
plan or to a cafeteria plan under Section 125 of the Code out of their
Separation Pay.

      3.6 INDIVIDUAL ARRANGEMENTS. Nothing in the Plan shall preclude the
Employer from entering into individual arrangements with employees for the
payment of severance benefits in addition to the benefits provided under the
Plan. No such individual arrangement shall entitle any person not a party
thereto to any benefits of any nature.

      3.7 TAX EFFECT OF PAYMENTS.

            (a) GROSS-UP PAYMENT. In the event that it is determined that any
      payment or distribution of any type to or for Participant's benefit made
      by the Employer, by any of its affiliates, by any person who acquires
      ownership or effective control of the Employer or ownership of a
      substantial portion of the Employer's assets (within the meaning of
      Section 280G of the Code and the regulations thereunder) or by any
      affiliate of such person, whether paid or payable or distributed or
      distributable pursuant to the terms of this Plan or otherwise (the "Total
      Payments"), would be subject to the excise tax imposed by Section 4999 of
      the Code or any interest or penalties with respect to such excise tax
      (such excise tax, together with any such interest or penalties, are
      collectively referred to as the "Excise Tax"), then a Participant shall be
      entitled to receive an additional payment (a "Gross-Up Payment") in an
      amount such that after payment by such Participant of all taxes imposed
      upon the Gross-Up Payment, including any Excise Tax, such Participant
      retains an amount of the Gross-Up Payment equal to the Excise Tax imposed
      on the Total Payments.

                                       7
<PAGE>

            (b) DETERMINATION BY ACCOUNTANT. All mathematical determinations and
      all determinations of whether any of the Total Payments are "parachute
      payments" (within the meaning of Section 280G of the Code) that are
      required to be made under this Section 3.7, including all determinations
      of whether a Gross-Up Payment is required, of the amount of such Gross-Up
      Payment and of amounts relevant to the last sentence of this Section 3.7,
      shall be made by an independent accounting firm selected by Employee and
      reasonably acceptable to the Company from among the largest four
      accounting firms in the United States (the "Accounting Firm"), which shall
      provide its determination, together with detailed supporting calculations
      regarding the amount of any Gross-Up Payment and any other relevant
      matters (the "Determination"), both to the Employer and to the Participant
      within five business days of the Participant's termination date, if
      applicable, or such earlier time as is requested by the Employer or the
      Participant (if the Participant reasonably believes that any of the Total
      Payments may be subject to the Excise Tax). If the Accounting Firm
      determines that no Excise Tax is payable by the Participant, it shall
      furnish the Participant with a written statement that such Accounting Firm
      has concluded that no Excise Tax is payable (including the reasons
      therefor) and that the Participant has substantial authority not to report
      any Excise Tax on the Participant's federal income tax return. If a
      Gross-Up Payment is determined to be payable, it shall be paid to the
      Participant within five business days after the Determination is delivered
      to the Employer or to the Participant. Any Determination by the Accounting
      Firm shall be binding upon the Employer and the Participant, absent
      manifest error. All of the costs and expenses of the Accounting Firm shall
      be borne by the Employer.

            (c) UNDERPAYMENTS AND OVERPAYMENTS. As a result of uncertainty in
      the application of Section 4999 of the Code at the time of the initial
      determination by the Accounting Firm hereunder, it is possible that
      Gross-Up Payments not made by the Employer should have been made
      ("Underpayments") or that Gross-Up Payments will have been made by the
      Employer which should not have been made ("Overpayments"). In either
      event, the Accounting Firm shall determine the amount of the Underpayment
      or Overpayment that has occurred. In the case of an Underpayment, the
      amount of such Underpayment shall promptly be paid by the Employer to or
      for the Participant's benefit. In the case of an Overpayment, the
      Participant shall, at the direction and expense of the Employer, take such
      steps as are reasonably necessary (including the filing of returns and
      claims for refund), follow reasonable instructions from, and procedures
      established by, the Employer and otherwise reasonably cooperate with the
      Employer to correct such Overpayment; provided, however, that (i) the
      Participant shall in no event be obligated to return to the Employer an
      amount greater than the net after-tax portion of the Overpayment that the
      Participant has retained or has received as a refund from the applicable
      taxing authorities and (ii) this provision shall be interpreted in a
      manner consistent with the intent of this Section 3.7, which is to make
      the Participant whole, on an after-tax basis, for the application of the
      Excise Tax, it being understood that the correction of an Overpayment may
      result in the Participant's repaying to the Employer an amount which is
      less than the Overpayment.

                                       8
<PAGE>

                                   SECTION 4
                         PLAN AMENDMENT AND TERMINATION

      4.1 EMPLOYER'S RIGHT TO AMEND OR TERMINATE PLAN. The Employer may amend or
terminate the Plan only as provided in the applicable one of the following
clauses:

            (a) DURING THE FIRST TWO YEARS. This Plan shall not be amended or
      terminated on or before the second anniversary of the Effective Date
      except as necessary pursuant to a majority vote of the Board taken
      consistently with an opinion of counsel to either the Employer or the
      Board that such amendment is required by applicable law; provided that the
      Employer shall thereupon use its best efforts to provide the Eligible
      Employees and the Participants with the value of the benefits intended
      under this Plan immediately prior to the effective date of the amendment.
      Appendices A and/or B may be amended as necessary pursuant to a majority
      vote of the Board to add Eligible Employees.

            (b) AFTER THE SECOND YEAR. Following the second anniversary of the
      Effective Date, the Employer may amend or terminate this Plan as follows:

                  (i) PRIOR TO A CHANGE IN CONTROL. Prior to the occurrence of a
            Change in Control and following the second anniversary of the
            Effective Date, the Employer may amend the Plan (including its
            Appendices) in any manner at any time, and from time to time, and
            may terminate the Plan at any time.

                  (ii) AFTER A CHANGE IN CONTROL. After the occurrence of a
            Change in Control and until the second anniversary of such Change in
            Control, this Plan shall not be terminated and shall be amended only
            in accordance with the provisions of clauses (a)or (b) of this
            Subsection 4.1.

      4.2 METHOD OF AMENDMENT OR TERMINATION. Any amendment or termination of
the Plan shall be made by a written instrument signed by an officer of the
Employer upon due authorization by the Board.

                                   SECTION 5
                               PLAN ADMINISTRATION

      5.1 COMMITTEE. The Committee shall be the "named fiduciary" of the Plan
for purposes of Section 402(a)(1) of ERISA, with authority to control and manage
the operation and administration of the Plan, and shall be the agent for service
of process against the Plan. The Committee shall have full power to administer
the Plan in all matters, subject to applicable requirements of law. For this
purpose, the Committee's power shall include, but shall not be limited to the
following authority, in addition to all other powers provided by the Plan:

            (a) To make and enforce such rules and procedures as the Committee
      deems necessary or proper for the efficient administration of the Plan;

                                       9
<PAGE>

            (b) To appoint such agents, counsel, accountants, consultants and
      other persons to participate in the administration of the Plan as the
      Committee deems appropriate;

            (c) To allocate and delegate the responsibilities of the Committee
      and to designate other persons to carry out any of the Committee's
      responsibilities; provided that any such allocation, delegation or
      designation shall be in writing and in accordance with applicable
      requirements of law;

            (d) To sue or be sued on behalf of the Plan and to appoint
      additional agents for service of process; and

            (e) To the fullest extent permitted by law, the Committee shall have
      the exclusive responsibility and discretion to decide all matters relating
      to eligibility, coverage or benefits under the Plan and to interpret all
      provisions of the Plan and to determine all matters relating to the
      operation and administration of the Plan. Any determination by the
      Committee shall be final to the maximum extent permitted by ERISA.

      5.2 RECORDS. The Committee shall maintain such records as it deems
necessary to determine benefits and eligibility under the Plan and shall make
available to each Participant such portions of the records under the Plan as
pertain to the Participant, for examination at reasonable times during normal
business hours.

      5.3 RELIANCE. In administering the Plan, the Committee shall be entitled
to the extent permitted by law to rely conclusively on all information
(including without limitation all tables, valuations, certificates, opinions and
reports) which is furnished by or in accordance with the instructions or
recommendations of accountants, counsel, actuaries, consultants or other experts
employed or engaged by the Committee.

      5.4 INDEMNIFICATION. Subject to the criteria set forth below, to the
maximum extent permitted by law, the Company will indemnify each member of the
Board of Directors and of the Committee as well as any other employee with
duties under the Plan against liabilities and expenses (including any amount
paid in settlement or by reason of a judgment) reasonably incurred by him or her
in connection with any claims against him or her by reason of the performance of
his or her duties under the Plan.

            (a) This indemnity will not apply if the individual (i) acted
      fraudulently or in bad faith in the performance of his or her duties
      relating to the Plan or (ii) fails to assist the Company in defending
      against the claim.

            (b) The Company will have the right to select counsel and to control
      the prosecution or defense of the suit.

            (c) The Company will not be required to indemnify a person for any
      amount incurred through any settlement unless the Company consents in
      writing to the settlement.

                                       10
<PAGE>

            (d) The indemnification obligation of the Company under this
      Subsection 5.4 will be reduced to the extent that payments are made for
      the benefit of the individual by reason of any insurance policy, fidelity
      bond, or other contractual agreement entered into by the Company that does
      not allow recourse against the individual.

            (e) Notwithstanding anything to the contrary set forth herein, the
      provisions of this Subsection 5.4:

                  (i) May not be amended retroactively to eliminate the
            indemnification obligation;

                  (ii) Will survive the termination of the Plan; and

                  (iii) Will last at least as long as the applicable statute of
            limitations.

                                   SECTION 6
                              MISCELLANEOUS MATTERS

      6.1 INFORMATION REQUIRED. Participants and Eligible Employees shall
provide the Committee with such information and evidence, and shall sign such
documents, as may be requested from time to time for the purpose of
administering the Plan.

      6.2 NO GUARANTY OF EMPLOYMENT. This Plan shall not be a contract of
employment between the Employer and any employee. Nothing contained in the Plan
document nor any action taken in connection with the adoption, operation or
maintenance of the Plan shall be construed as a contract of employment between
the Employer and any employee or as consideration or inducement for the
employment of any employee. Nothing in the Plan or in the adoption, operation or
maintenance of the Plan shall give any employee the right to remain in the
Employer's employ, nor shall it give the Employer the right to require any
employee to remain in its employ, nor shall it interfere with the employee's
right to terminate his or her employment at any time. Without limiting the
generality of the foregoing, the Employer shall have the right to terminate or
change the terms of employment of any employee, Eligible Employee or Participant
at any time and for any reason whatsoever, with or without cause or notice.

      6.3 EXCLUSIVE PLAN. Except as provided in Section 3.6 or to the extent
otherwise expressly provided herein or in any separate agreement between the
Employer (or its successor following a Change in Control) and an Eligible
Employee, this Plan shall exclusively govern any claims for any type of
severance benefits as a result of any termination of employment due to a Covered
Termination on or after the Effective Date, while the Plan remains in effect.
Any other generally applicable severance plans of any nature maintained by the
Employer shall be terminated as of such Effective Date with respect to any
claims for severance benefits as a result of any Covered Termination occurring
on or after such Effective Date in consideration for the benefits provided under
the Plan.

      6.4 SOLE SOURCE FOR PAYMENT OF BENEFITS. All benefits provided under the
Plan shall be paid solely from the general assets of the Employer. Nothing in
the Plan shall be construed to require the Employer or the Committee to maintain
any fund or segregate any amount for the benefit of any Participant, and no
Participant or any other person shall have any claim against,

                                       11
<PAGE>

right to, or security or other interest in, any fund, account or asset of the
Employer from which any payment under the Plan may be made. Neither the Employer
nor any director, officer, employee or agent or other representative of the
Employer shall be liable, otherwise than as expressly provided in the Plan, for
payment of any benefits under the Plan or shall have any other liability to a
Participant or to any other person.

      6.5 NON-ALIENATION. No benefit payable under the Plan shall be subject in
any manner whatsoever to alienation, sale, transfer, assignment, pledge,
attachment or encumbrance of any kind, and each and every attempt to alienate,
sell, transfer, assign, pledge, attach or encumber any such benefit under the
Plan shall be void.

      6.6 NO VESTING. Except as otherwise expressly provided in this Plan, no
person shall have any vested or non-forfeitable interest at any time in any
payment or other benefit provided under the Plan. The Employer shall have the
right to withhold from benefit payments any amounts that the Participant owes to
the Employer.

      6.7 OBLIGATIONS TO WITHHOLD AND PAY TAXES. Each Participant shall be
liable for all tax obligations, if any, with respect to any sum received or
other benefit provided pursuant to the Plan and for accurately reporting all
such income and paying in full all such taxes to the appropriate federal, state
and local authorities. The Employer shall have the right to deduct and withhold
from any payment due under the Plan or from other amounts owed to the
Participant all withholding taxes and other amounts required by law.

      6.8 GOVERNING LAW. The Plan and the rights of all persons under the Plan
shall be construed in accordance with ERISA.

                                   SECTION 7
                                CLAIMS PROCEDURE

      7.1 CLAIM FOR BENEFITS.

            (a) Any person claiming benefits under the Plan ("Claimant") may be
      required to submit an application therefor, together with such other
      documents and information as the Committee may require ("Application").

            (b) Within 90 days following receipt of the Application, the
      Committee's authorized delegate reviewing the claim will furnish the
      Claimant with written notice of the decision rendered with respect to the
      Application.

            (c) Should special circumstances require an extension of time for
      processing the claim, written notice of the extension will be furnished to
      the Claimant prior to the expiration of the initial 90 day period.

                  (i) The notice will indicate the special circumstances
            requiring an extension of time and the date by which a final
            decision is expected to be rendered.

                                       12
<PAGE>

                  (ii) In no event will the period of the extension exceed 90
            days from the end of the initial 90 day period.

      7.2 CONTENT OF DENIAL. In the case of a denial of the Claimant's
Application, the written notice will set forth:

            (a) The specific reasons for the denial;

            (b) References to the Plan provisions upon which the denial is
      based;

            (c) A description of any additional information or material
      necessary for perfection of the Application together with an explanation
      of why the material or information is necessary;

            (d) An explanation of the Plan's claim review procedure; and

            (e) The Claimant's right to bring a civil action under Section
      502(a) of ERISA.

      7.3 APPEALS.

            (a) In order to appeal the decision rendered with respect to his or
      her Application or with respect to the amount of his or her benefit, the
      Claimant must follow the procedures set forth in this Section 7.3

            (b) The appeal must be made in writing:

                  (i) If the claim was expressly rejected, within 65 days after
            the date of notice of the decision with respect to the Application;
            or

                  (ii) If the claim was neither approved nor denied within the
            applicable period provided in Subsection 7.1 of this Plan, within 65
            days after the expiration of that period.

            If the Claimant does not file the appeal within this time period (or
      request in writing an extension from the Committee), the Claimant will be
      precluded from appealing the decision at a later time.

                  (iii) The Claimant may request that his or her Application be
            given full and fair review by the Committee. The Claimant may review
            all pertinent documents and submit issues and comments in writing in
            connection with the appeal.

                  (iv) The decision of the Committee will be made promptly, and
            not later than 60 days after the Committee's receipt of a request
            for review, unless special circumstances require an extension of
            time for processing. In such a case, a decision will be rendered as
            soon as possible, but not later than 120 days after receipt of the
            request for review.

                                       13
<PAGE>

                  (v) The Committee's decision on review will be in writing and
            will include specific reasons for the decision, written in a manner
            designed to be understood by the Claimant, with specific references
            to the pertinent Plan provisions upon which the decision is based.

      7.4 LEGAL ACTIONS. No legal action for benefits or relating to any other
aspect of the Plan may be brought unless and until the Claimant has exhausted
his remedies under this Section 7.4 Also, any facts or legal theories that are
not presented in the claims procedure may not be raised in any such legal
actions.

            (a) A Claimant will not be considered to have exhausted his remedies
      unless and until:

                  (i) The Claimant has submitted an Application;

                  (ii) The claim for benefits has been either:

                        (A) Expressly denied; or

                        (B) Neither approved nor denied within the applicable
                  time period under Section 7.1;

                  (iii) The Claimant has appealed the denial of benefits under
            Section 7.3; and

                  (iv) The Claimant's appeal has been either:

                        (A) Expressly denied; or

                        (B) Neither approved nor denied within the applicable
                  time period under Section 7.3.

            (b) Any legal actions based upon a claim for benefits or any other
      aspect of the Plan must be brought within two years after the Claimant's
      right to the current payment of benefits accrued.

      7.5 REQUIREMENT OF RELEASE. In the case of a contested claim for benefits,
the Committee may require, as a precondition to the entitlement of any claims
for benefits, that the Claimant execute an agreement releasing any claims he
asserts that he has against the Company, Plan, and the Committee (as well as all
other fiduciaries of the Plan).

                                   SECTION 8
                                  ERISA RIGHTS

      The Plan is subject to the provisions of Title I of ERISA (which imposes
requirements relating to reporting and disclosure obligations, minimum
participation, fiduciary responsibility, and enforcement). The Plan is not
subject to Title IV of ERISA (which insures the benefits payable under certain
defined benefit pension plans).

                                       14
<PAGE>

      As a participant in the Plan, you are entitled to certain rights and
protections under ERISA. ERISA provides that all Plan participants are entitled
to:

            i. Examine, without charge, at the Plan Administrator's office, all
      Plan documents, including insurance contracts and copies of all documents
      filed by the Plan Administrator with the U.S. Department of Labor, such as
      detailed annual reports;

            ii. Obtain copies of all Plan documents and other Plan information
      upon written request to the Plan Administrator. The Plan Administrator may
      make a reasonable charge for copies; and

            iii. Receive a summary of the Plan's annual financial report. The
      Plan Administrator is required by law to furnish each participant with a
      copy of this summary financial report.

      In addition to creating rights for Plan participants, ERISA imposes duties
upon the people who are responsible for the operation of the Plan. The people
who operate your Plan, called "fiduciaries" of the Plan, have a duty to act
prudently and exclusively in the interests of you and other Plan participants
and beneficiaries.

      No one, including your employer, or any other person, may fire you or
otherwise discriminate against you in any way to prevent you from obtaining a
benefit or exercising your rights under ERISA.

      If your claim for benefits is denied, in whole or in part, you must
receive a written explanation of the reason for the denial. You have the right
to have the Committee review and reconsider your claim as described above.

      Under ERISA, there are steps you can take to enforce the above rights. For
instance, if you request materials from the Plan and do not receive them within
30 days, you may file suit in a federal court. In such a case, the court may
require the Plan Administrator to provide the materials and pay you up to $110 a
day until you receive the materials, unless the materials were not sent because
of reasons beyond the control of the Plan Administrator.

      If you have a claim for benefits which is denied or ignored, in whole or
in part, you may file suit in a state or federal court. If it should happen that
Plan fiduciaries misuse the Plan's money, or if you are discriminated against
for asserting your rights, you may seek assistance from the U.S. Department of
Labor, or you may file suit in a federal court.

      The court will decide who should pay court costs and legal fees. If you
are successful, the court may order the person you have sued to pay these costs
and fees. If you lose, the court may order you to pay these costs and fees, for
example, if the court finds that your claim is frivolous.

      If you have any questions about your Plan, you should contact the
Committee. If you have any questions about this statement or about your rights
under ERISA, you should contact the nearest Area Office of the Pension and
Welfare Benefits Administration, U.S. Department of Labor, listed in your
telephone directory or the Division of Technical Assistance and Inquiries,

                                       15
<PAGE>

Pension and Welfare Benefits Administration, U.S. Department of Labor, 200
Constitution Avenue N.W., Washington, D.C. 20210.

      IN WITNESS WHEREOF, the Employer, by its duly authorized officer, has
executed this document.

                                         ENDOCARE, INC.

                                         By: /s/ Paul W. Mikus
                                             -------------------------
                                               Paul W. Mikus
                                               Chief Executive Officer

                                       16
<PAGE>

                      SUMMARY PLAN DESCRIPTION INFORMATION

The Plan Administrator is:

Endocare, Inc.
201 Technology Drive
Irvine, California 92618
Telephone: (949) 450-5400
EIN:  33-0618093

The Plan Number is: 503

                                       17
<PAGE>

                        APPENDIX A TO THE ENDOCARE, INC.
                       EXECUTIVE SEPARATION BENEFITS PLAN

      DESIGNATION OF ELIGIBLE EMPLOYEES AS OF JULY 17, 2002, PURSUANT TO
SUBSECTION 2.8:

Paul W. Mikus

John V. Cracchiolo

Jay Eum

Kevin Quilty

Paul Lapine

Bill Phillips

Dave Battles

Mary Syiek

                                       18
<PAGE>

                        APPENDIX B TO THE ENDOCARE, INC.
                       EXECUTIVE SEPARATION BENEFITS PLAN

Paul W. Mikus                                   2 times Base Pay

John V. Cracchiolo                              2 times Base Pay

Jay Eum                                         1 times Base Pay

Kevin Quilty                                    1 times Base Pay

Paul Lapine                                     1/2 times Base Pay

Bill Phillips                                   1/2 times Base Pay

Dave Battles                                    1/2 times Base Pay

Mary Syiek                                      1/2 times Base Pay

                                       19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00059-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00059-of-00352.parquet"}]]